PRB strives to provide the Program and the clinical research community with high quality and well characterized chemical substances and drug products. The parenteral and oral formulations developed by the branch are chosen to be safe and cause no undue discomfort to the patients. Whenever possible, USP/NF grade excipients with proven track record for consistency and safety are used. The clinical supplies provided by PRB are guaranteed to meet or exceed FDA accepted potency and purity requirements while in use. The end use stability studies are designed to provide maximum comfort to the patients and convenience for the health care professionals. Our general philosophy is to keep our operations simple and provide the best possible and most expedient service to our "customers."
PRB contract resources are generally used for drug candidates selected for clinical development. PRB becomes involved when drug candidates are approved by either the Decision Network (DN) Committee or the RAID mechanism.